Topics

Cellectis and Lonza Enter cGMP Manufacturing Service Agreement for Cellectis' Allogeneic UCART Product Candidates

16:31 EDT 1 Oct 2019 | FinanzNachrichten

Agreement covers manufacturing of clinical supply for Cellectis' UCART pipeline Manufacturing to take place at Lonza's GMP site in Geleen, Netherlands Regulatory News: Cellectis (Paris:ALCLS) (NAS...

Original Article: Cellectis and Lonza Enter cGMP Manufacturing Service Agreement for Cellectis' Allogeneic UCART Product Candidates

NEXT ARTICLE

More From BioPortfolio on "Cellectis and Lonza Enter cGMP Manufacturing Service Agreement for Cellectis' Allogeneic UCART Product Candidates"

Quick Search

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...